Anemone Franz is a physician with a background in global health and infectious diseases. She works as an advisor at the nonprofit organisation 80,000 Hours, where she focuses on biosecurity and emerging technologies. Previously, she was a clinical trial physician at Alvea, a start-up company aiming to accelerate medical countermeasure development and deployment for pandemic prevention. Anemone is an Emerging Leaders in Biosecurity Fellow at the Johns Hopkins Center for Health Security.
Anemone Franz
Physician and Biosecurity/Emerging Disruptive Technologies Advisor
Content by Anemone Franz
Commentary
Existential threats beyond the bomb: emerging disruptive technologies in the age of AI
To better understand emerging technologies, NEVER members Konrad, Anemone, Emil, Arthur, and Joel outline the evolution of the risk landscape around emerging disruptive technologies and draw parallels between the dangers posed by nuclear weapons and those posed by novel biotechnologies. They explore the broader challenge of governing emerging technologies and suggest potential ways forward.